Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease

Haritha Kirla, David Henry, Shirley Jansen, Peter Thompson, Juliana Hamzah

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)

Abstract

Purpose: Cardiovascular disease (CVD) is the leading cause of death worldwide. The current CVD therapeutic drugs require long-term treatment with high doses, which increases the risk of adverse effects while offering only marginal treatment efficacy. Silica nanoparticles (SNPs) have been proven to be an efficient drug delivery vehicle for numerous diseases, including CVD. This article reviews recent progress and advancement in targeted delivery for drugs and diagnostic and theranostic agents using silica nanoparticles to achieve therapeutic efficacy
and improved detection of CVD in clinical and preclinical settings.
Methods: A search of PubMed, Scopus, and Google Scholar databases from 1990 to 2023 was conducted. Current clinical trials on silica nanoparticles were
identified through ClinicalTrials.gov. Search terms include silica nanoparticles, cardiovascular diseases, drug delivery, and therapy.
Findings: Silica nanoparticles exhibit biocompatibility in biological systems, and their shape, size, surface area, and surface functionalization can be customized for the safe transport and protection of drugs in blood circulation. These properties also enable effective drug uptake in specific tissues and controlled drug release after systemic, localized, or oral delivery. A range of silica nanoparticles have been used as nanocarrier for drug delivery to treat conditions such as atherosclerosis, hypertension, ischemia, thrombosis, and myocardial infarction.
Implications: The use of silica nanoparticles for drug delivery and their ongoing development has emerged as a promising strategy to improve the effectiveness of drugs, imaging agents, and theranostics with the potential to
revolutionize the treatment of CVD.
Original languageEnglish
Pages (from-to)1060-1068
Number of pages9
JournalClinical Therapeutics
Volume45
Issue number11
DOIs
Publication statusPublished - Nov 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this